Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Neurosterix
Advanced allosteric modulator therapeutics developer for neurological disorders.
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 11 Sep, 2024
"update inverses"
Golden AI
edited on 11 Sep, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Funding Rounds
Neurosterix April 2024 Series A Funding Round
"Funding autocalculation"
Golden AI
edited on 11 Sep, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Latest Funding Type
Series A
"update inverses"
Golden AI
edited on 11 Sep, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Funding Rounds
Neurosterix April 2024 Series A Funding Round
Edits on 15 Aug, 2024
"update entity type supersets"
Golden AI
edited on 15 Aug, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Is a
Organization
"Created via: prospector:3932:4137820"
Ivo Devereux
created this topic on 15 Aug, 2024
Edits made to:
Infobox
(
+14
properties)
Description
(
+80
characters)
Neurosterix
Advanced allosteric modulator therapeutics developer for neurological disorders.
Infobox
Is a
Company
Industry
Health technology
Biotechnology
Official Website
https://neurosterix.com
Number of Employees (Ranges)
1 – 10
Investors
Perceptive Advisors
Xontogeny
Acorn Bioventures
Founded Date
2024
Total Funding Amount (USD)
63,000,000
Latest Funding Round Date
April 3, 2024
Country
Switzerland
Headquarters
Geneva
Latest Funding Round Amount (USD)
63,000,000
Find more companies like Neurosterix
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE